• Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
  • Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care.
  • We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company.
  • Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.

CRP Test Procedure

1. Dilute sample   2. Apply sample
Procedure Step 1 Procedure Step2
Mix 5 µL whole blood with Dilution Liquid. Mix well Apply 50 µL diluted sample to the Test Device
   
3. Apply Conjugate 4. Wash
Procedure Step3 Procedure Step 4
Apply one drop Conjugate Apply one drop Washing Solution
   
5. Read  
Read  
Read the test result with the NycoCard READER II  

 

Please always refer to the product instructions for full details on how to perform the assay and appropriate safety information.

Axis-Shield at a Glance

A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.

About Us

› More about Axis-Shield

Focus on Afinion

Axis-Shield's award winning point-of-care test system is designed for maximum simplicity coupled with laboratory accuracy and reliability for a number of key markers important for improved patient management.

Play Afinion Demo

Afinion features

© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland. - E: shield@axis-shield.com
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.